Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Affect Allosteric Ca²⁺ Activation of the α4β2 Nicotinic Acetylcholine Receptor by Rodrigues-Pinguet, Nivalda O. et al.
ONLINE SUPPLEMENTAL INFORMATION

This supplement contains a derivation of Eq. 3 in the text.  To determine whether a change in allosteric Ca2+ activation could explain the effects of the ADNFLE mutations on the Ca2+ concentration‑potentiation relation, we developed a simple kinetic model for allosteric Ca2+ activation of the 42 receptor.  Previous results show that (1) Ca2+ appears to increase the neuronal nicotinic acetylcholine response by increasing the probability of channel opening, rather than by relieving receptor inactivation (Amador and Dani, 1995), and (2) Ca2+ increases the 7 maximum acetylcholine response (Galzi et al., 1996).  Based on these results, we modeled allosteric Ca2+ activation as follows,  
		(Scheme 1)
where A is the agonist (acetylcholine in this case); R is the receptor; A2R* and A2R*Ca are the sole conducting states; K1, K2, K3, mK2, and mK3 are equilibrium constants; and, m is the factor by which channel opening changes the equilibrium constant for Ca2+ binding to the receptor.  For simplicity, we combined the binding of two agonist molecules to the receptor into a single step and we omitted any rapid desensitization that might occur during the rising phase of the acetylcholine response (2 s).  We also assumed that (1) agonist binding does not affect the Ca2+ affinity of the non‑conducting states (R, A2R) and (2) the A2R* and A2R*Ca states have the same single‑channel conductance.  These restrictions were necessary to reduce the number of free parameters in the model.  According to Scheme 1, channel opening changes the Ca2+ affinity of the receptor by a factor of m-1.  The direction of Ca2+ modulation (whether it increases or decreases the probability of channel opening) depends on m.  If m is < 1, then Ca2+ increases the probability of channel opening and allosterically activates the receptor.  If m is >1, then Ca2+ has the opposite effect and allosterically inhibits the receptor.  Thermodynamic balance requires that, when Ca2+ is bound to the receptor, the equilibrium constants for agonist binding and channel opening are K1 and mK2, respectively.  Given assumption 1 (above), Ca2+ should change both the agonist efficacy and potency.  However, if we relax this restriction and let Ca2+ affect agonist binding as well as channel opening (i.e., allow states R and A2R to have different Ca2+ affinities), then a Ca2+‑induced increase in agonist efficacy would not necessitate an increase in agonist potency (Galzi et al., 1996).  Solving Scheme 1 for the combined steady‑state probability of being in the open states, A2R* and A2R*Ca, we have
		(4)
where the brackets around the states denote the fractional occupancy of a particular state and those around the ligands denote their concentration.  If the [Ca2+]o = 0, then the steady‑state open probability becomes 
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For a fixed [A], the relative Ca2+‑induced increase in the combined probability of being in the open states A2R* and A2R*Ca is, 
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At large [Ca2+]os, the Ca2+ potentiation of the open probability approaches a maximum value (Pmax),
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Using Eq. 7 and replacing mK3 with KCa, we can rewrite Eq. 3 as follows,
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where KCa is now the equilibrium constant for Ca2+ binding to the open state.  If we assume that the peak acetylcholine response is proportional to the steady‑state open probability, then the relation between the [Ca2+]o and the Ca2+‑induced fractional change in the peak acetylcholine response (ICa/I0) at a fixed [A] is, 
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where the ICa is the peak acetylcholine response when the [Ca2+]o is > 0 mM and I0 is the peak response when it is zero.  According to Scheme 1, the ADNFLE mutations could affect Ca2+ potentiation by changing the parameters m, K2, or K3.  If the mutations reduce Ca2+ potentiation by decreasing K2 (i.e., increasing agonist efficacy in the absence of Ca2+), then their effects on Ca2+ potentiation would depend on the acetylcholine concentration.  As the acetylcholine concentration approaches zero, Eq. 6 becomes, 
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Note that K2 does not appear in this equation.  Thus, if the mutations affect only K2, then they would not affect Ca2+ potentiation at the foot of the acetylcholine concentration‑potentiation relation.  However, as the acetylcholine concentration increased towards saturation, the mutations would reduce Ca2+ potentiation.  The maximum mutant‑induced reduction in Ca2+ potentiation would occur at a saturating acetylcholine concentration where Eq. 6 becomes,
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In contrast, mutant‑induced changes in m or K3 would affect Ca2+ potentiation at all acetylcholine concentrations.


